NCT06357507

Brief Summary

moraxella catarrhalis is responsible for respiratory tract infection in children and adults with streptococcus pneumonia and haemophilus influenza.Moraxella catarrhalis is gram negative diplococci, non-motile and non spore bearing bacteria. Until, 1995 it was considered as a non pathogenic respiratory tract flora.This bacteria is an important pathogen and a common cause of both upper and lower respiratory tract infections, pneumonia, sinusitis and conjunctivitis in infants, children and in elderly patients. In adults, M. catarrhalis also causes chronic obstructive pulmonary disease (COPD) and pneumonia. However, it is associated with a number of respiratory infections affecting both children and adults, including laryngitis, bronchitis and pneumonia .

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
19mo left

Started Dec 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Dec 2024Dec 2027

First Submitted

Initial submission to the registry

April 5, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2027

Last Updated

April 16, 2024

Status Verified

April 1, 2024

Enrollment Period

3 years

First QC Date

April 5, 2024

Last Update Submit

April 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • isolation of moraxella catarrhalis

    isolation of organism on muller hinton agar

    3 years

Secondary Outcomes (2)

  • detection of virulence genes of moraxella catarrhalis

    3 years

  • detetion of antibiotic resistance

    3years

Eligibility Criteria

Age1 Month+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

children with respiratory tract infection

You may qualify if:

  • all children with bacterial pneumonia

You may not qualify if:

  • viral pneumonia , tuberculosis and immunocompromised

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008 Nov 27;359(22):2355-65. doi: 10.1056/NEJMra0800353. No abstract available.

    PMID: 19038881BACKGROUND
  • Blakeway LV, Tan A, Peak IRA, Seib KL. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development. Microbiology (Reading). 2017 Oct;163(10):1371-1384. doi: 10.1099/mic.0.000523. Epub 2017 Sep 12.

    PMID: 28893369BACKGROUND
  • Bernhard S, Spaniol V, Aebi C. Molecular pathogenesis of infections caused by Moraxella catarrhalis in children. Swiss Med Wkly. 2012 Oct 29;142:w13694. doi: 10.4414/smw.2012.13694. eCollection 2012.

    PMID: 23136074BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

sputum samples for DNA extraction and PCR

MeSH Terms

Conditions

Respiratory Tract Infections

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
faculty of medicine meical microbiology and immunology

Study Record Dates

First Submitted

April 5, 2024

First Posted

April 10, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 20, 2027

Last Updated

April 16, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

ethical consideration